Michael Robin Witt
Algemeen Directeur bij GABATHER AB
Actieve functies van Michael Robin Witt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GABATHER AB | Directeur/Bestuurslid | 01-09-2014 | - |
| Algemeen Directeur | 01-10-2018 | - | |
| Investor Relations Contact | - | - | |
| Lead Discovery Malaysia Sdn. Bhd. | Algemeen Directeur | 01-01-2012 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | - |
Loopbaan van Michael Robin Witt
Eerdere bekende functies van Michael Robin Witt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Hoofd Techniek/Wetenschap/O&O | 01-09-2010 | 01-04-2012 |
| Oprichter | 01-01-2007 | 01-04-2012 | |
| KARO PHARMA AB (PUBL) | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | - | - |
Opleiding van Michael Robin Witt
| Vrije Universiteit Brussel | Doctorate Degree |
| Danmarks Farmaceutiske Universitet | Doctorate Degree |
Statistieken
Internationaal
| Zweden | 5 |
| Denemarken | 3 |
| België | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Transportation | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| KARO PHARMA AB (PUBL) | Health Technology |
| GABATHER AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| Lead Discovery Malaysia Sdn. Bhd. |
- Beurs
- Insiders
- Michael Robin Witt
- Ervaring
